Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,410
-90 (-0.78%)
Last updated: Mar 28, 2025

Whan In Pharm Statistics

Total Valuation

Whan In Pharm has a market cap or net worth of KRW 174.20 billion. The enterprise value is 122.03 billion.

Market Cap 174.20B
Enterprise Value 122.03B

Important Dates

The next estimated earnings date is Friday, May 2, 2025.

Earnings Date May 2, 2025
Ex-Dividend Date Dec 27, 2024

Share Statistics

Whan In Pharm has 15.27 million shares outstanding.

Current Share Class n/a
Shares Outstanding 15.27M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 28.36%
Owned by Institutions (%) 18.72%
Float 10.94M

Valuation Ratios

The trailing PE ratio is 7.45 and the forward PE ratio is 8.62.

PE Ratio 7.45
Forward PE 8.62
PS Ratio 0.67
PB Ratio 0.46
P/TBV Ratio 0.47
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.82, with an EV/FCF ratio of -18.31.

EV / Earnings 5.22
EV / Sales 0.47
EV / EBITDA 3.82
EV / EBIT 5.20
EV / FCF -18.31

Financial Position

The company has a current ratio of 4.75, with a Debt / Equity ratio of 0.00.

Current Ratio 4.75
Quick Ratio 3.03
Debt / Equity 0.00
Debt / EBITDA 0.01
Debt / FCF -0.06
Interest Coverage 929.61

Financial Efficiency

Return on equity (ROE) is 6.37% and return on invested capital (ROIC) is 3.65%.

Return on Equity (ROE) 6.37%
Return on Assets (ROA) 3.25%
Return on Invested Capital (ROIC) 3.65%
Return on Capital Employed (ROCE) 5.62%
Revenue Per Employee 446.04M
Profits Per Employee 40.17M
Employee Count 582
Asset Turnover 0.63
Inventory Turnover 2.62

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -22.01% in the last 52 weeks. The beta is 0.17, so Whan In Pharm's price volatility has been lower than the market average.

Beta (5Y) 0.17
52-Week Price Change -22.01%
50-Day Moving Average 11,636.20
200-Day Moving Average 12,977.05
Relative Strength Index (RSI) 41.45
Average Volume (20 Days) 12,166

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Whan In Pharm had revenue of KRW 259.60 billion and earned 23.38 billion in profits. Earnings per share was 1,531.45.

Revenue 259.60B
Gross Profit 93.66B
Operating Income 21.50B
Pretax Income 26.95B
Net Income 23.38B
EBITDA 29.97B
EBIT 21.50B
Earnings Per Share (EPS) 1,531.45
Full Income Statement

Balance Sheet

The company has 52.58 billion in cash and 413.74 million in debt, giving a net cash position of 52.17 billion or 3,416.99 per share.

Cash & Cash Equivalents 52.58B
Total Debt 413.74M
Net Cash 52.17B
Net Cash Per Share 3,416.99
Equity (Book Value) 376.00B
Book Value Per Share 24,628.27
Working Capital 158.92B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 20.69 billion and capital expenditures -27.36 billion, giving a free cash flow of -6.66 billion.

Operating Cash Flow 20.69B
Capital Expenditures -27.36B
Free Cash Flow -6.66B
FCF Per Share -436.48
Full Cash Flow Statement

Margins

Gross margin is 36.08%, with operating and profit margins of 8.28% and 9.01%.

Gross Margin 36.08%
Operating Margin 8.28%
Pretax Margin 10.38%
Profit Margin 9.01%
EBITDA Margin 11.54%
EBIT Margin 8.28%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 300.00, which amounts to a dividend yield of 2.63%.

Dividend Per Share 300.00
Dividend Yield 2.63%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 19.59%
Buyback Yield n/a
Shareholder Yield 2.63%
Earnings Yield 13.42%
FCF Yield -3.83%
Dividend Details

Stock Splits

The last stock split was on April 14, 2010. It was a forward split with a ratio of 2.

Last Split Date Apr 14, 2010
Split Type Forward
Split Ratio 2

Scores

Whan In Pharm has an Altman Z-Score of 5.03.

Altman Z-Score 5.03
Piotroski F-Score n/a